BioPontis Alliance for Rare Diseases

πŸ“ Raleigh, United StatesπŸ—“ Founded 2014
BioPontis Alliance for Rare Diseases is a non-profit corporation dedicated to the development of new therapeutic agents to treat rare diseases. The niche philanthropy uses a collaborative approach, partnering with patient organizations and academic researchers. BioPontis provides the plans and executes the preclinical translational scientific, early clinical development, patenting, and business relationship management. We bring the expertise that is needed to advance ideas for treatments into drug compounds that are ready for uptake by the biopharmaceutical and biotech industry. BioPontis Alliance for Rare Diseases is a global non-profit development hub, inviting corporate, private and foundation philanthropic support to address a global community of people affected with rare diseases whose health needs are too often neglected as β€˜too rare to care.’
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2014
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was BioPontis Alliance for Rare Diseases founded?
BioPontis Alliance for Rare Diseases was founded in 2014.
What industry is BioPontis Alliance for Rare Diseases in?
BioPontis Alliance for Rare Diseases operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is BioPontis Alliance for Rare Diseases based?
BioPontis Alliance for Rare Diseases is headquartered in Raleigh, United States.